Clinical Trial Update: Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors [Phase 2]

View source ↗

Summary

Phase 2 study assessing pathological responses in metastatic colorectal cancer metastases resected after preoperative treatment with cetuximab plus FOLFOX or FO…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Cetuximab (cetuximab)
• Folinic acid (folinic acid)
• Irinotecan (Irinotecan)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: TERMINATED